4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-23-004238
Chief Executive Officer acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myers Scott Dunseth Chief Executive Officer | 2023-02-06 | Grant or award | +250,000 | 250,000 | D | ||
| Derivatives | |||||||
| Myers Scott Dunseth Chief Executive Officer | 2023-02-06 | Grant or award · Stock Option (Right to Buy) | +1,000,000 | 1,000,000 | D | ||
Loading xslF345X03/doc4.xml…